Hólyagrák: vizsgálatok itt: Spanyolország
60 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 17.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleSymbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
- Where
- Barcelona, Madrid, Santander, Seville
- Életkor
- 18 év and over
- People
- 132 worldwide
- Run by
- Pfizer
See details and how to joinNCT07421700 · EU 2025-523523-21-00 - 3. fázisTaking peopleA Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Where
- Badajoz, Badalona, Barakaldo, Barcelona, Córdoba, Elche, Girona, Hospitalet, Las Palmas de Gran Canaria, Madrid, Málaga, Pamplona, Pozuelo de Alarcón, Reus, Santander, Santiago de Compostela, Seville, Valencia
- Életkor
- 18 év and over
- People
- 450 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07218380 · EU 2025-522855-25-00 - 2. fázisNot yet taking people in SpanyolországFeasibility study of Neo-adjuvant (before surgery) versus Adjuvant (after surgery) chemotherapy in Upper Tract Urothelial Carcinoma
- Where
- A Coruña, Badalona, Barcelona, Bilbao, Cartagena, Ciudad Real, Girona, Granada, Jerez de la Frontera, Las Palmas de Gran Canaria, Las Palmas De Gran Canaria, Madrid, Murcia, Palma, Pamplona, Sabadell, Salamanca, Santander, Santiago De Compostela, Sevilla, Valencia, Zaragoza
- Életkor
- 18 év and over
- People
- 196 worldwide
- Run by
- European Uro-Oncology Group Stichting
See details and how to joinNCT02969083 · EU 2024-514991-41-01 - 1/2. fázisTaking peopleKEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
- Where
- Barcelona, Madrid
- Életkor
- 18 év and over
- People
- 55 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07232602 · EU 2025-522253-19-00 - 1. fázisTaking peopleStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Badajoz, Barcelona, Madrid, Pamplona, Santander, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 1394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00 - 2. fázisTaking peopleA Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- Where
- Las Palmas de Gran Canaria, Madrid, Pozuelo de Alarcón, Sabadell, Sevilla
- Életkor
- 18 év and over
- People
- 308 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06833073 · EU 2024-517335-46-00 - 3. fázisNot yet taking people in SpanyolországA Phase III, Open-Label, Randomised, Multicentre, Global Study of Adjuvant Datopotamab Deruxtecan in Combination With Rilvegostomig in Participants With High-risk Muscle Invasive Urothelial Carcinoma.
- Where
- Las Palmas de Gran Canaria, L'Hospitalet de Llobregat, Madrid, Santander, Sevilla
- Életkor
- 18 év to 64 év
- People
- 262 worldwide
- Run by
- AstraZeneca AB
See details and how to join2025-525030-57-00 - 2. fázisFut, nem toborozA study to find out if enfortumab vedotin given with pembrolizumab helps people with muscle-invasive bladder cancer keep their bladder.
- Where
- Elche, Granada, Las Palmas de Gran Canaria, L'hospitalet De Llobregat, Madrid, Ourense, Oviedo, Pamplona, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 88 worldwide
- Run by
- Astellas Pharma Global Development Inc.
See details and how to join2025-524488-18-00 - 4. fázisTaking peopleA Rollover Study to Follow the Long-term Durability of Response to UGN-103 in Participants With Recurrent Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer (LG-IR-NMIBC) From Study BL013
- Where
- Madrid
- Életkor
- 18 év and over
- People
- 33 worldwide
- Run by
- Urogen Pharma Ltd.
See details and how to join2026-526359-75-00 - 1/2. fázisNot yet taking people in SpanyolországLow-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis
- Where
- Barcelona
- Életkor
- 18 év and over
- People
- 20 worldwide
- Run by
- Ferring Pharmaceuticals
See details and how to joinNCT06668493 · EU 2024-514360-70-00 - No phaseTaking peopleORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Where
- A Coruña, Barcelona, Girona, Las Palmas de Gran Canaria, Madrid, Málaga, Sabadell, Santiago de Compostela, Valencia
- Életkor
- 18 év and over
- People
- 2285 worldwide
- Run by
- Guardant Health, Inc.
See details and how to joinNCT05059444 - 1. fázisTaking peopleA Phase 1/1b Study of IAM1363 in HER2 Cancers
- Where
- Barcelona, Madrid, Málaga, Seville, Valencia
- Életkor
- 18 év and over
- People
- 383 worldwide
- Run by
- Iambic Therapeutics, Inc
See details and how to joinNCT06253871 - 3. fázisTaking peopleRoll Over StudY for Patients Who Have Completed a Previous Oncology Study with Durvalumab
- Where
- Barcelona, Girona, Madrid, Marbella, Santiago De Compostela, Valencia
- Életkor
- 18 év and over
- People
- 87 worldwide
- Run by
- Astrazeneca AB
See details and how to joinNCT05303532 · EU 2023-507337-22-00 - 3. fázisTaking peopleA Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
- Where
- A Coruña, Barcelona, Cadiz, Córdoba, Madrid, Murcia, Seville, Valencia
- Életkor
- 18 év and over
- People
- 70 worldwide
- Run by
- UroGen Pharma Ltd.
See details and how to joinNCT06774131 · EU 2024-519343-15-00 - 1/2. fázisTaking peopleA Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- Where
- Barcelona, Girona, Madrid, Majadahonda, Palma, Pamplona, Pozuelo de Alarcón, Sabadell, Salamanca, Santiago de Compostela, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04104776 · EU 2023-508002-20-00 - 1/2. fázisTaking peopleA Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Where
- Badalona, Barcelona, Madrid, Málaga, Pamplona
- Életkor
- 18 év and over
- People
- 1109 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04895709 - 1/2. fázisTaking peopleA Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- Where
- Barcelona, Madrid, Valencia
- Életkor
- 18 év and over
- People
- 366 worldwide
- Run by
- Marengo Therapeutics, Inc.
See details and how to joinNCT05592626 · EU 2023-505334-10-01 - 1/2. fázisTaking peopleLEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- Where
- Badalona, Barcelona, L'hospitalet De Llobregat, Madrid, Murcia, Pozuelo de Alarcón, San Sebastián de los Reyes, Santander
- Életkor
- 18 év and over
- People
- 350 worldwide
- Run by
- enGene, Inc.
See details and how to joinNCT04752722 · EU 2024-512900-20-00 - 2/3. fázisTaking peoplePhase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
- Where
- Badajoz, Barcelona, Córdoba, Madrid, Santander, Seville, Valencia
- Életkor
- 18 év and over
- People
- 470 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07106762 - 2. fázisTaking peopleA Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Where
- Barcelona, Madrid, Santiago de Compostela, Sevilla, Valencia
- Életkor
- 8 év and over
- People
- 254 worldwide
- Run by
- Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00 - 2. fázisNot yet taking people in SpanyolországGenitourinary Tumors With Sacituzumab Tirumotecan
- Where
- Madrid
- Életkor
- 18 év and over
- People
- 100
- Run by
- Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD
See details and how to joinNCT07716917 · EU 2026-526048-10-00 - 2. fázisFut, nem toborozA Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
- Where
- Badalona, Barcelona, Madrid, Sabadell, Santander, Sevilla
- Életkor
- 18 év and over
- People
- 372 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT04879329 · EU 2022-500030-28-01 - 3. fázisNot yet taking people in SpanyolországAn Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
- Where
- Las Palmas de Gran Canaria, L'Hospitalet de Llobregat, Madrid, Santander, Seville
- Életkor
- 18 év and over
- People
- 915 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07720284 - 1. fázisTaking peopleA Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Where
- Barcelona, Elche, Jerez de la Frontera, Madrid, Málaga, Santander
- Életkor
- 18 év and over
- People
- 1006 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT04389632 · EU 2023-508469-34-00 - 1/2. fázisTaking peopleA Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
- Where
- Barcelona, Córdoba, El Palmar, Madrid, Seville, Tarragona, Valencia
- Életkor
- 18 év and over
- People
- 180 worldwide
- Run by
- Alentis Therapeutics AG
See details and how to joinNCT07169734 · EU 2025-521441-24-00